Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$5.27bnn/an/a
au flag iconMSBMesoblastAU$2.83bnn/an/a
au flag iconPYCPYC TherapeuticsAU$1.14bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$1.08bnn/an/a
au flag iconRACRacura OncologyAU$479.17mn/an/a
au flag iconCGSCogstateAU$406.58m27.770.77%
au flag iconTTXTetratherixAU$241.59mn/an/a
au flag iconBXNBioxyneAU$155.78m18.13n/a
au flag iconACWActinogen MedicalAU$149.78mn/an/a
au flag iconNYRNyradaAU$141.09mn/an/a
au flag iconDXBDimerixAU$129.09mn/an/a
au flag iconATHAlterity TherapeuticsAU$119.63mn/an/a
au flag iconILAIsland PharmaceuticalsAU$94.84mn/an/a
au flag iconALAArovella TherapeuticsAU$91.29mn/an/a
au flag iconIMMImmutepAU$88.42mn/an/a
au flag iconCYPCynata TherapeuticsAU$79.55mn/an/a
au flag iconLTPLtr PharmaAU$79.02mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$68.56mn/an/a
au flag iconATXAmplia TherapeuticsAU$66.70mn/an/a
au flag iconGD8GO-DX (Aust)AU$61.94mn/an/a